Reported Standalone quarterly numbers for Procter & Gamble Health are:Net Sales at Rs 320.92 crore in March 2023 up 19.83% from Rs. 267.82 crore in March 2022.
Quarterly Net Profit at Rs. 59.19 crore in March 2023 up 15.7% from Rs. 51.16 crore in March 2022.
EBITDA stands at Rs. 84.63 crore in March 2023 up 19% from Rs. 71.12 crore in March 2022.
Procter&Gamble EPS has increased to Rs. 35.70 in March 2023 from Rs. 30.82 in March 2022.
Procter&Gamble shares closed at 4,736.95 on May 12, 2023 (NSE) and has given 9.46% returns over the last 6 months and 8.89% over the last 12 months.
| Procter & Gamble Health | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 320.92 | 309.97 | 267.82 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 320.92 | 309.97 | 267.82 | | EXPENDITURE | | Consumption of Raw Materials | 63.62 | 101.08 | 73.56 | | Purchase of Traded Goods | 20.49 | 7.73 | 4.09 | | Increase/Decrease in Stocks | 15.95 | -27.39 | 3.17 | | Power & Fuel | -- | -- | -- | | Employees Cost | 60.73 | 47.26 | 45.05 | | Depreciation | 5.89 | 9.75 | 6.12 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -2.13 | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 82.60 | 70.91 | 73.18 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 73.77 | 100.63 | 62.65 | | Other Income | 4.97 | 4.54 | 2.35 | | P/L Before Int., Excpt. Items & Tax | 78.74 | 105.17 | 65.00 | | Interest | 0.21 | 0.23 | 0.14 | | P/L Before Exceptional Items & Tax | 78.53 | 104.94 | 64.86 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 78.53 | 104.94 | 64.86 | | Tax | 19.34 | 28.14 | 13.70 | | P/L After Tax from Ordinary Activities | 59.19 | 76.80 | 51.16 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 59.19 | 76.80 | 51.16 | | Equity Share Capital | 16.60 | 16.60 | 16.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 35.70 | 46.30 | 30.82 | | Diluted EPS | 35.70 | 46.30 | -- | | EPS After Extra Ordinary | | Basic EPS | 35.70 | 46.30 | 30.82 | | Diluted EPS | 35.70 | 46.30 | -- | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|